Herbal medicinal product: Pelargonii radixArray,Array, F: Assessment finalised

Public webinar on pack size submissions: from XEVMPD to product management service (PMS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 July 2024, 10:00 (CEST) to 11 July 2024, 11:30 (CEST)

Exploring GLP-1 Receptor Agonists: Instagram LIVE Q&A, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 22 July 2024, 18:00 (CEST) to 22 July 2024, 18:30 (CEST)

EMEA-002886-PIP01-20-M03

EMEA-002631-PIP01-19-M02

Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, Efgartigimod alfa, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Haematology-Hemostaseology, PIP number: P/0252/2023

EMEA-002572-PIP02-19-M03

EMEA-002472-PIP03-22-M01

Opinion/decision on a Paediatric investigation plan (PIP): Mounjaro, Tirzepatide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0285/2023

Opinion/decision on a Paediatric investigation plan (PIP): Ayvakyt, Avapritinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0281/2023